ASAkram Seifollahi

Akram Seifollahi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akram Seifollahi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pregnancy in Non-communicating Rudimentary Horn

    by Ladan Kashani, Atefeh Khezri, Akram Seifollahi, Zahra Gharibi

    Background: Pregnancy in the rudimentary horn of the unicornuate uterus is highly rare. Its incidence is 1 in 75000-150000 pregnancies. It is difficult to diagnose the rudimentary horn of the unicornuate uterus before the rupture of an ectopic pregnancy. Case Presentation: The current study reports the case of a 35-year-old Iranian mother with a natural contraceptive method. The mother was a primigravida woman at the gestational age of 7 weeks, based on her last period. She complained of abdominal pain in the right and lower abdomen and had a positive pregnancy test with a beta-human chorionic gonadotropin beta-human chorionic gonadotropin (beta-hCG) titration of 38982 on May 17, 2021. The ultrasound report on May 17, 2021, showed a right adnexal mass with a size of 32*32*31 and a fetal pole, and yolk sac. A fetal heart of six weeks and one day in favor of ectopic pregnancy was detected. and its endometrial thickness was 12 mm. There were no abdominal or pelvic-free fluids. Thus, after being diagnosed with an ectopic pregnancy that included a heart, the patient was transferred to the operating room for laparoscopy. During laparoscopy, we found that the pregnancy was in the rudimentary horn of the unicornuate uterus. The rudimentary horn was resected, and the salpingectomy of the right side was performed for the patient. The samples were then transferred to the laboratory for pathological analysis. Conclusion: We should increase awareness about pregnancies that occur in this uterine abnormality so that there is a high suspicion index for faster diagnosis before the rupture of ectopic pregnancy and worse events can be prevented accordingly.

  • Open Access

    A New Model Including AMH Cut-off Levels to Predict Post-treatment Ovarian Function in Early Breast Cancer: A Prospective Cohort Study

    by Ramesh Omranipour, Fatemeh Ahmadi-Harchegani, Azin Saberi, Ashraf Moini, Mostafa Shiri, Amirmohsen Jalaeefar, Arvin Arian, Akram Seifollahi, Mahshad Madani, Bita Eslami, et al.

    Background: Breast cancer (BC) treatment decreases fertility capacity, but unnecessary fertility preservation procedures in women who would not be infertile after treatment would be a waste of time and resources and could cause the unwarranted exposure of cancer cells to exogenous sex hormones. It has been largely shown that post-treatment ovarian reserve is directly associated with pre-treatment anti-mullerian hormone levels (AMH0). A threshold for AMH0, or a model including AMH0 and patient characteristics that could distinguish the patients who will be infertile after treatments, still needs to be defined. Accordingly, this study was performed to specifically target this high-priority concern. Methods: Women≤45 years old with newly diagnosed non-metastatic BC were entered in this multicenter prospective cohort study. AMH0 and two-year post-treatment AMH (AMH2) were measured, and hormonal patient features were recorded as well. Receiver operating characteristic (ROC) curve analysis, decision tree (DT), and random forest analyses were performed to find a cut-off point for AMH0 and define a model involving related features for the prediction of AMH2. Results: The data from 84 patients were analyzed. ROC curve analysis revealed that AMH0>3 ng/mL (Area under the curve=0.69, 95% CI: 0.54‒0.84) was the best indicator for predicting AMH2≥0.7 (sensitivity=79%, specificity=60%). The best model detected by DT and random forest for predicting an AMH2>0.7 with a probability of 93% consisted of a combination of AMH0>3.3, menarche age<14, and age<31. Conclusion: This combination model can be used to withhold fertility preservation procedures in BC patients. Performing larger studies is suggested to further test this model.


  • Open Access

    Spectrum of ultrasound findings in patients with history of breast conservative treatment

    by Fatemeh Shakki Katouli, Leila Bayani, Fahimeh Azizinik, Somayeh Fathi, Akram Seifollahi, Fatemeh Zare Bozorgabadi

    Breast conservative treatment (BCT) is currently accepted as the standard treatment option for breast cancer. Targeted ultrasound helps detect recurrent lesions, postoperative changes, and scarring tissue. In this pictorial essay, we review the ultrasound features of benign (seroma, hematoma, fat necrosis, traumatic neuroma, fibrosis/scarring) and malignant (recurrence, new primary cancer) causes of palpable lumps after BCT and provide images from our patients to illustrate some typical findings of common pathologies. Ultrasound, especially as an adjunct to mammography, can make a specific diagnosis in most cases.

  • Comparison of cytopathologic findings in patients with negative Pap test and positive high-risk HPV infection among three groups

    by Sara Kasraei, Akram Ghahghaei-Nezamabadi, Akram Seifollahi, Faezeh Aghajani, Amin Nakhostin-Ansari, Neda Zarei, Afsaneh Tehranian

    Purpose Comparison of colposcopy-guided biopsy and endocervical cytologic (ECC) results in patients with negative Papanicolaou (Pap) and positive high-risk (HR) HPV tests in the three groups of HPV 16/18, non-16/18 HR-HPV (other HR-HPV), and concurrent infection of either HPV 16/18 and at least one subtype of other HR-HPVs. Methods This cross-sectional study was conducted among women aged 30–65 who had negative Pap and positive HR-HPV DNA tests. Pap test was performed using liquid cytology. For HPV DNA testing, the polymerase chain reaction (PCR) method was used. Results Among 394 participants, 111 (28.2%) were in the HPV 16/18, 226 (57.4%) in the Other HR-HPV, and 57 (14.4%) in the concurrent group. The mean age of participants was 35.71 ± 7.1 years. Cervical intraepithelial neoplasia (CIN) grade 2/3 were seen in 29 (26.1%) patients of HPV 16/18, 60 (26.5%) of other HR-HPV, and 18 (31.6%) of concurrent infection group (P = 0.593). HPV 52 was the most common subtype in the other HR-HPV group (15%). Conclusions The risk of high-grade CIN lesions in patients with negative Pap test and positive other HR-HPV was not significantly less than patients with positive HPV 16/18. Besides, the risk of losing the patients to 1-year follow-up seems high.


  • Open Access

    Risk Factors and Prevalence of Vitamin D Deficiency Among Iranian Women Attending Two University Hospitals

    by Sadaf Alipour, Azin Saberi, Akram Seifollahi, Nooshin Shirzad, Ladan Hosseini

    Background: Several studies indicated that there is a high prevalence of vitamin D deficiency in Middle East countries. Objectives: The aim of this study was to determine the prevalence and assess some risk factors of vitamin D deficiency among women attending our clinics in Tehran, the capital of Iran. Patients and Methods: Five hundred and thirty-eight women aged 20-80 years were entered in this cross-sectional study from 2011 to 2012. Serum 25-hydroxy vitamin D levels were measured in all participants after recruiting their demographic and anthropometric data and past medical histories. Deficiency was defined as levels less than 35 nmol/L and classified as mild (≥ 25 nmol/L), moderate (12.5-25 nmol/L) and severe (≤ 12.5 nmol/L). Results: The prevalence of vitamin D deficiency was 69%; mild, moderate and severe degrees were seen in %10.4, %38.3, and %20.3 respectively. Analysis of logistic regression shows that age (OR:0.96, CI: 0.93-0.97), menopause (OR: 0.44, CI: 0.21-0.99) and consumption of multivitamin supplements (OR: 2.67, CI: 1.4-5) were independent predictive factors for Vitamin D deficiency. Conclusions: This study showed a high prevalence of vitamin D deficiency among Iranian women especially in reproductive ages. Keywords: Vitamin D; Deficiency; Prevalence; Iran